{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:32:45Z","timestamp":1782480765846,"version":"3.54.5"},"reference-count":94,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","respiratoryinvestigation.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.resinv.2016.11.004","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T23:45:31Z","timestamp":1484351131000},"page":"94-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["The clinical impact of major comorbidities on idiopathic pulmonary fibrosis"],"prefix":"10.1016","volume":"55","author":[{"given":"Atsushi","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-5459","authenticated-orcid":false,"given":"Yasuhiro","family":"Kondoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2016.11.004_bib1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement. Idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3111\/13696998.2012.680553","article-title":"Burden of illness in idiopathic pulmonary fibrosis","volume":"15","author":"Collard","year":"2012","journal-title":"J Med Econ"},{"key":"10.1016\/j.resinv.2016.11.004_bib3","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1164\/rccm.201010-1752OC","article-title":"Viral infection in acute exacerbation of idiopathic pulmonary fibrosis","volume":"183","author":"Wootton","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S2213-2600(14)70069-4","article-title":"Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.","volume":"2","author":"Han","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib5","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1164\/rccm.201403-0541OC","article-title":"The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis","volume":"190","author":"Molyneaux","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/thoraxjnl-2012-202403","article-title":"Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomized controlled trial","volume":"68","author":"Shulgina","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2016.11.004_bib7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1183\/09031936.05.00021005","article-title":"Groupe d\u2019Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P). Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity","volume":"26","author":"Cottin","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2016.11.004_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1378\/chest.12-2403","article-title":"Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis","volume":"144","author":"Ryerson","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2016.11.004_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1378\/chest.08-2306","article-title":"Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension","volume":"136","author":"Mejia","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2016.11.004_bib10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1440-1843.2010.01778.x","article-title":"The effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosis","volume":"15","author":"Kurashima","year":"2010","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2016.11.004_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1440-1843.2009.01676.x","article-title":"Clinical characteristics of combined pulmonary fibrosis and emphysema","volume":"15","author":"Kitaguchi","year":"2010","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2016.11.004_bib12","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.rmed.2008.03.022","article-title":"Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis","volume":"102","author":"Nathan","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib13","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1378\/chest.129.3.746","article-title":"Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis","volume":"129","author":"Lettieri","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2016.11.004_bib14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1183\/09031936.00107206","article-title":"Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant","volume":"30","author":"Shorr","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2016.11.004_bib15","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1378\/chest.06-1466","article-title":"Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis","volume":"131","author":"Hamada","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2016.11.004_bib16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000345221","article-title":"Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis","volume":"85","author":"Kimura","year":"2013","journal-title":"Respiration"},{"key":"10.1016\/j.resinv.2016.11.004_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1183\/09031936.00115511","article-title":"Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis","volume":"40","author":"Judge","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2016.11.004_bib18","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.rmed.2014.07.020","article-title":"Lung cancer in patients with idiopathic pulmonary fibrosis: clinical characteristics and impact on survival","volume":"108","author":"Lee","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1378\/chest.14-0359","article-title":"The impact of lung cancer on survival of idiopathic pulmonary fibrosis","volume":"147","author":"Tomassetti","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2016.11.004_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1164\/ajrccm.161.1.9906062","article-title":"Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study","volume":"161","author":"Hubbard","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib21","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1164\/rccm.200710-1501OC","article-title":"Japan Thoracic Radiology Group. Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study","volume":"177","author":"Kudoh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1440-1843.2010.01907.x","article-title":"The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer","volume":"16","author":"Usui","year":"2011","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2016.11.004_bib23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.lungcan.2010.04.014","article-title":"The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias","volume":"71","author":"Minegishi","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2016.11.004_bib24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000342046","article-title":"Efficacy of chemotherapy for advanced non-small cell lung cancer with idiopathic pulmonary fibrosis","volume":"85","author":"Watanabe","year":"2013","journal-title":"Respiration"},{"key":"10.1016\/j.resinv.2016.11.004_bib25","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00280-014-2458-0","article-title":"Safety and efficacy of gemcitabine or pemetrexed in combination with a platinum in patients with non-small-cell lung cancer and prior interstitial lung disease","volume":"73","author":"Choi","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.resinv.2016.11.004_bib26","first-page":"1697","article-title":"Vinorelbine and cisplatin in patients with advanced non-small cell lung cancer with interstitial pneumonia","volume":"35","author":"Watanabe","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.resinv.2016.11.004_bib27","first-page":"4259","article-title":"Efficacy and safety of combined carboplatin, paclitaxel, and bevacizumab for patients with advanced non-squamous non-small cell lung cancer with pre-existing interstitial lung disease: a retrospective multi-institutional study","volume":"35","author":"Enomoto","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.resinv.2016.11.004_bib28","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/JTO.0b013e3182103d3c","article-title":"The feasibility study of Carboplatin plus Etoposide for advanced small cell lung cancer with idiopathic interstitial pneumonias","volume":"6","author":"Minegishi","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.resinv.2016.11.004_bib29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10147-013-0554-5","article-title":"Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis","volume":"19","author":"Watanabe","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.resinv.2016.11.004_bib30","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.jtcvs.2013.09.050","article-title":"Japanese Association for Chest Surgery. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer","volume":"147","author":"Sato","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.resinv.2016.11.004_bib31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jtcvs.2014.08.086","article-title":"Japanese Association for Chest Surgery. Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases","volume":"149","author":"Sato","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.resinv.2016.11.004_bib32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s11748-014-0487-6","article-title":"A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients","volume":"63","author":"Sato","year":"2015","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.resinv.2016.11.004_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1183\/09031936.06.00037005","article-title":"High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis","volume":"27","author":"Raghu","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2016.11.004_bib34","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00101212","article-title":"Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients","volume":"42","author":"Savarino","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2016.11.004_bib35","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1164\/rccm.201101-0138OC","article-title":"Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis","volume":"184","author":"Lee","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib36","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1183\/09031936.00050911","article-title":"Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis","volume":"39","author":"Lee","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2016.11.004_bib37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S2213-2600(13)70105-X","article-title":"IPF net Investigators. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomized controlled trials","volume":"1","author":"Lee","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib38","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1164\/rccm.200602-163OC","article-title":"Incidence and prevalence of idiopathic pulmonary fibrosis","volume":"174","author":"Raghu","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib39","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1164\/ajrccm.158.6.9804105","article-title":"Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis","volume":"158","author":"Tobin","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib40","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1378\/chest.14-0041","article-title":"Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based study","volume":"147","author":"Dalleywater","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2016.11.004_bib41","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1164\/rccm.200805-725OC","article-title":"The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study","volume":"178","author":"Hubbard","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib42","first-page":"289","article-title":"Association between idiopathic pulmonary fibrosis and coronary artery disease: a case-control study and cohort analysis","volume":"31","author":"Kim","year":"2015","journal-title":"Sarcoidosis Vasc Diffus Lung Dis"},{"key":"10.1016\/j.resinv.2016.11.004_bib43","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.rmed.2010.02.008","article-title":"Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis","volume":"104","author":"Nathan","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib44","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1183\/09031936.00099614","article-title":"Venous thromboembolism in people with idiopathic pulmonary fibrosis: a population-based study","volume":"44","author":"Dalleywater","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2016.11.004_bib45","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1378\/chest.123.6.2007","article-title":"Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis","volume":"123","author":"Enomoto","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2016.11.004_bib46","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.rmed.2008.11.001","article-title":"Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis","volume":"103","author":"Gribbin","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib47","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.rmed.2014.01.008","article-title":"How does comorbidity influence survival in idiopathic pulmonary fibrosis?","volume":"108","author":"Hyldgaard","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib48","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00408-007-9004-3","article-title":"Sleep-related breathing disorders in patients with idiopathic pulmonary fibrosis","volume":"185","author":"Mermigkis","year":"2007","journal-title":"Lung"},{"key":"10.1016\/j.resinv.2016.11.004_bib49","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1378\/chest.08-2776","article-title":"Obstructive sleep apnea is common in idiopathic pulmonary fibrosis","volume":"136","author":"Lancaster","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2016.11.004_bib50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11325-010-0336-5","article-title":"How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis","volume":"14","author":"Mermigkis","year":"2010","journal-title":"Sleep Breath"},{"key":"10.1016\/j.resinv.2016.11.004_bib51","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.rmed.2011.02.016","article-title":"Comparison of biomarkers of subclinical lung in obstructive sleep apnea","volume":"105","author":"Aihara","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib52","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1183\/09031936.00150708","article-title":"Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnea","volume":"33","author":"Lederer","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2016.11.004_bib53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1183\/16000617.00009114","article-title":"Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night","volume":"24","author":"Schiza","year":"2015","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.resinv.2016.11.004_bib54","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1183\/13993003.02316-2014","article-title":"Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review","volume":"46","author":"Raghu","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2016.11.004_bib55","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1183\/09031936.00217614","article-title":"Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry","volume":"46","author":"Behr","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2016.11.004_bib56","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1164\/rccm.201403-0566OC","article-title":"Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences","volume":"190","author":"Natsuizaka","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib57","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1378\/chest.103.6.1808","article-title":"Acute exacerbation in idiopathic pulmonary fibrosis.\u00a0Analysis of clinical and pathologic findings in three cases","volume":"103","author":"Kondoh","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2016.11.004_bib58","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","article-title":"Acute exacerbations of idiopathic pulmonary fibrosis","volume":"176","author":"Collard","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib59","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report","volume":"194","author":"Collard","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib60","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1103690","article-title":"Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis","volume":"365","author":"Richeldi","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib61","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib62","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1183\/09031936.00005209","article-title":"Pirfenidone Clinical Study Group in Japan. Pirfenidone in idiopathic pulmonary fibrosis","volume":"35","author":"Taniguchi","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2016.11.004_bib63","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201202-0314OC","article-title":"A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis","volume":"186","author":"Noth","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib64","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1183\/13993003.00419-2015","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm","volume":"46","author":"Ryerson","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2016.11.004_bib65","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib66","first-page":"103","article-title":"Risk factors of acute exacerbation of idiopathic pulmonary fibrosis","volume":"27","author":"Kondoh","year":"2010","journal-title":"Sarcoidosis Vasc Diffus Lung Dis"},{"key":"10.1016\/j.resinv.2016.11.004_bib67","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1183\/09031936.06.00114004","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features","volume":"27","author":"Kim","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2016.11.004_bib68","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1183\/09031936.00159709","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome","volume":"37","author":"Song","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2016.11.004_bib69","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1183\/09031936.00122213","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure","volume":"43","author":"Johannson","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2016.11.004_bib70","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00408-013-9530-0","article-title":"Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis","volume":"192","author":"Kishaba","year":"2014","journal-title":"Lung"},{"key":"10.1016\/j.resinv.2016.11.004_bib71","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.rmed.2014.04.009","article-title":"Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis","volume":"108","author":"Ohshimo","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib72","doi-asserted-by":"crossref","first-page":"e0116775","DOI":"10.1371\/journal.pone.0116775","article-title":"Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis","volume":"10","author":"Schupp","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2016.11.004_bib73","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.resinv.2015.04.005","article-title":"Risk factors for acute exacerbation of idiopathic pulmonary fibrosis--Extended analysis of pirfenidone trial in Japan","volume":"53","author":"Kondoh","year":"2015","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2016.11.004_bib74","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.rmed.2006.02.002","article-title":"Acute exacerbation of interstitial pneumonia following surgical lung biopsy","volume":"100","author":"Kondoh","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib75","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00408-012-9389-5","article-title":"Exacerbations in idiopathic pulmonary fibrosis triggered by pulmonary and nonpulmonary surgery: a case series and comprehensive review of the literature","volume":"190","author":"Ghatol","year":"2012","journal-title":"Lung"},{"key":"10.1016\/j.resinv.2016.11.004_bib76","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.rmed.2011.11.006","article-title":"Acute exacerbation of IPF following diagnostic bronchoalveolar lavage procedures","volume":"106","author":"Sakamoto","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib77","first-page":"960316","article-title":"Postoperative acute exacerbation of IPF after lung resection for primary lung cancer","volume":"211","author":"Watanabe","year":"2011","journal-title":"Pulm Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib78","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s11604-008-0261-8","article-title":"Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing","volume":"26","author":"Takeda","year":"2008","journal-title":"Radiat Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib79","doi-asserted-by":"crossref","first-page":"e482","DOI":"10.1371\/journal.pone.0000482","article-title":"Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern","volume":"2","author":"Selman","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2016.11.004_bib80","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S2213-2600(16)00067-9","article-title":"Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis","volume":"4","author":"Kreuter","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib81","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1164\/rccm.200808-1339ED","article-title":"Idiopathic pulmonary fibrosis: a shot through the heart?","volume":"178","author":"Zisman","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib82","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11325-014-1033-6","article-title":"Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis","volume":"19","author":"Mermigkis","year":"2015","journal-title":"Sleep Breath"},{"key":"10.1016\/j.resinv.2016.11.004_bib83","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"ATS\/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib84","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1164\/rccm.200702-220OC","article-title":"Idiopathic nonspecific interstitial pneumonia: lung manifestation of an undifferentiated connective tissue disease?","volume":"176","author":"Kinder","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib85","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1378\/chest.10-0194","article-title":"Connective tissue disease-associated interstitial lung disease: a call for classification","volume":"138","author":"Fischer","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2016.11.004_bib86","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1378\/chest.10-2662","article-title":"Autoimmune-featured interstitial lung disease: a distinct entity","volume":"140","author":"Vij","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2016.11.004_bib87","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2016.11.004_bib88","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1164\/ajrccm.149.6.8004317","article-title":"Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis","volume":"149","author":"Wells","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib89","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","article-title":"Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease","volume":"127","author":"Lee","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2016.11.004_bib90","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.rmed.2015.01.009","article-title":"Broader criteria of undifferentiated connective tissue disease in idiopathic interstitial pneumonias","volume":"109","author":"Kondoh","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2016.11.004_bib91","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1378\/chest.14-0272","article-title":"Interstitial pneumonia related to undifferentiated connective tissue disease: pathologic pattern and prognosis","volume":"147","author":"Kim","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2016.11.004_bib92","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1378\/chest.14-3174","article-title":"Lung-dominant connective tissue disease: clinical, radiologic, and histologic features","volume":"148","author":"Omote","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2016.11.004_bib93","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1183\/09031936.00165111","article-title":"Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes","volume":"40","author":"Reddy","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2016.11.004_bib94","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1378\/chest.13-2866","article-title":"Distinct characteristics of pleuroparenchymal fibroelastosis with usual interstitial pneumonia compared with idiopathic pulmonary fibrosis","volume":"146","author":"Oda","year":"2014","journal-title":"Chest"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534516301988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534516301988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T23:23:47Z","timestamp":1536103427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534516301988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S2212534516301988"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2016.11.004","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727384824.793539205","asserted-by":"object"}]},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical impact of major comorbidities on idiopathic pulmonary fibrosis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2016.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}